GenSight Biologics Confirms 2nd Successful GMP Batch of LUME

GenSight Biologics Confirms 2nd Successful GMP Batch of LUMEVOQ® and Eligibility to Draw Down Bridge Financing 2nd Tranche of €4 million

GenSight Biologics Confirms 2nd Successful GMP Batch of LUMEVOQ® and Eligibility to Draw Down Bridge Financing 2nd Tranche of €4 million

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Paris , France General , France , Thomas Gidoin , Gensight Biologics , Guillaume Van Renterghem , Bernard Gilly , Gensight Biologics Euronext , European Medicines Agency , Sofinnova Partners , Sight Biologics , Good Manufacturing Practice , Chief Executive Officer , Bridge Financing , Sight Biologic , Mitochondrial Targeting Sequence , Leber Hereditary Optic Neuropathy , Gensight Biologic , Institut De La Vision , Adeno Associated Virus , Process Performance Qualification , Marketing Authorisation Application , Biologics License Application ,